Definicja
Dihydropteridine reductase (DHPR) deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4) (see this term), leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties.
Definicja
Dihydropteridine reductase (DHPR) deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4) (see this term), leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties.
Dane
Klasyfikacja
Podtyp kliniczny
Synonimy
Hyperphenylalaninemia due to dihydropteridine reductase deficiency
Fenyloketonuria typu 2
Hiperfenyloalaninemia spowodowana niedoborem reduktazy dihydropterydyny
PKU typu 2
PKU type 2
Phenylketonuria type 2
Kod ORPHA
226
Kod OMIM
261630
Kod ICD10
E70.1
Kod ICD11
5C59.01
Brak opisu rozszerzonego dla tej choroby. Opracowanie w toku.
Orphanet - interntowa baza danych dotyczących rzadkich chorób i sierochych leków. ©INSERM 1999 - Dostępna na stronie www.orphanet.pl